Literature DB >> 15528881

Semi-intensive monitoring in acute stroke and long-term outcome.

Yolanda Silva1, Montserrat Puigdemont, Mar Castellanos, Joaquín Serena, Rosa M Suñer, María M García, Antoni Dávalos.   

Abstract

BACKGROUND AND
PURPOSE: Factors that determine the benefit of stroke units (SU) are unknown. The aim of our study was to analyze whether semi-intensive monitoring during the acute phase of stroke reduces mortality and dependency at long term.
METHODS: We studied patients with an ischemic stroke or intracerebral hemorrhage, consecutively admitted to our SU within 24 h of symptoms onset. Based on bed availability, patients were allocated to either a conventional care stroke unit (C-SU, n = 209) or a semi-intensive stroke unit (SI-SU, n = 321) with continuous monitoring of cardiac, respiratory, metabolic and neurological functions during the first 72 h. Both groups were treated following the same medical and nursing protocols. Criteria for exclusion were patients with stupor/coma, previously dependent (Barthel score <85) and with TIA. Using logistic regression models, we analyzed the influence of semi-intensive care on mortality and dependency at one year.
RESULTS: Baseline characteristics were similar between patients admitted to the SI-SU and the C-SU, except for a higher frequency of more severe stroke and intracerebral hemorrhage in the SI-SU. Twenty-six percent of patients in the SI-SU and 4% in the C-SU were randomized in acute clinical trials (p < 0.01), and 61% and 39% were seen by a neurologist in less than 6 h from the onset of symptoms (p < 0.01). At 1 year, mortality and combined mortality and dependency were not significantly different between the two groups. However, due to the presence of a significant interaction between the type of unit and stroke severity, the OR of mortality for SI-SU allocation was 0.19 (95% CI, 0.07-0.54) in patients with severe stroke (CSS < or =4), whereas it was 0.64 (95% CI, 0.37-1.11) in those with mild-to-moderate stroke.
CONCLUSIONS: This study suggests that semi-intensive monitoring in a stroke unit reduces mortality at 1 year in patients with severe stroke, with no influence over dependency.

Entities:  

Mesh:

Year:  2004        PMID: 15528881     DOI: 10.1159/000081908

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  Acute stroke unit care and early neurological deterioration in ischemic stroke.

Authors:  Jaume Roquer; Ana Rodríguez-Campello; Meritxell Gomis; Jordi Jiménez-Conde; Elisa Cuadrado-Godia; Rosa Vivanco; Eva Giralt; Maria Sepúlveda; Claustre Pont-Sunyer; Gracia Cucurella; Angel Ois
Journal:  J Neurol       Date:  2008-06-02       Impact factor: 4.849

2.  Stroke management.

Authors:  Kameshwar Prasad; Subhash Kaul; M V Padma; S P Gorthi; Dheeraj Khurana; Asha Bakshi
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

3.  The SOS pilot study: a RCT of routine oxygen supplementation early after acute stroke--effect on recovery of neurological function at one week.

Authors:  Christine Roffe; Khalid Ali; Anushka Warusevitane; Sheila Sills; Sarah Pountain; Martin Allen; John Hodsoll; Frank Lally; Peter Jones; Peter Crome
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

4.  The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six months.

Authors:  Khalid Ali; Anushka Warusevitane; Frank Lally; Julius Sim; Sheila Sills; Sarah Pountain; Tracy Nevatte; Martin Allen; Christine Roffe
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

Review 5.  Organised inpatient (stroke unit) care for stroke.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

6.  Early physical activity and discharge destination after stroke: a comparison of acute and comprehensive stroke unit care.

Authors:  Tanya West; Leonid Churilov; Julie Bernhardt
Journal:  Rehabil Res Pract       Date:  2013-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.